Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2005-05-24
2005-05-24
Campell, Bruce R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C424S236100, C424S247100, C514S002600, C530S350000, C435S071300
Reexamination Certificate
active
06896886
ABSTRACT:
A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting ofBotulinumtoxin types A, B, C, D, E, F and G.
REFERENCES:
patent: 2373454 (1945-04-01), Bumy et al.
patent: 2719102 (1955-09-01), Baldwin
patent: 3132995 (1964-05-01), Berger et al.
patent: 4713240 (1987-12-01), Wilkins et al.
patent: 4932936 (1990-06-01), Dykstra et al.
patent: 5053005 (1991-10-01), Borodic
patent: 5055291 (1991-10-01), Lam et al.
patent: 5055302 (1991-10-01), Laties et al.
patent: 5183462 (1993-02-01), Borodic
patent: 5437291 (1995-08-01), Pasricha et al.
patent: 5766605 (1998-06-01), Sanders et al.
patent: 6113915 (2000-09-01), Aoki et al.
patent: 9528171 (1995-10-01), None
Greene et al. “Use of Botulinum Toin Type F Injection to Treat Torticollis in Patients with Immunity of Botulinum Toxin type A.” Movement disorders. vol. 8, No. 4, p. 479-483. 1993.*
Clark, J.B. “Cervical Dystonia Following Exposure to High-G Forces” Aviat. Space Environ. Me. 1990. vol. 61, pp. 935-937. 1990.*
File Biosis of STN. DN. No. BA84:79401. Reichl et al. “Hyperesthesia Associated with Hyperextention Injures of the Neck.” Injury, vol. 18, No. 4, p. 234. Abstract Only.*
Cervical Dystonia [online], [retrieved Sep. 3, 2003]. Retrieved from <URL:www.fpnotebook.com/NEU151.htm> pp. 1-2.*
Purngvarin et al; J. Med. Assoc. Thai. (Apr. 1992) 75 (4) 199-203 (Abstract).
Correspondence Dated Dec. 10, 1991 Between William C. Sheppard and Ira Sanders.
Correpondence Dated Apr. 13, 1992 Between Ira Sanders and Angelika S. Aswad Regarding “Animal Study”.
Partial Correspondence Dated Apr. 24, 1992 Between Angelika S. Aswad and Dr. Sanders Regarding Botulinum Toxin to Decrease Salivary Flow.
Ambache, J. Physiol. (1951) 113, 1-17.
Brin, Arch. De Neurobiol. 54, Supl. 3 (7-23) 1991.
Jenzer, G., et al.;Type B Botulism, Report on Mild Courses with Predominantly Autonomic Nervous Impairment; Schweiz. Med. Wschr.; 104, 685-693; 1974. (English translation also enclosed.).
Aoki K. Roger
Carlson Steven R.
Grayston Michael W.
Leon Judith M.
Allergan Inc.
Baran Robert J.
Campell Bruce R.
Donovan Stephen
Gupta Anish
LandOfFree
Use of botulinum toxins for treating various disorders and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of botulinum toxins for treating various disorders and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of botulinum toxins for treating various disorders and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3393364